Can AI Revolutionise Remote Lung and Heart Screening in European Healthcare?

person holding a stress ball
Photo by Matthias Zomer on Pexels.com

With every passing moment, technology is changing the way healthcare is delivered. A shining example of this revolution is StethoMe, a startup based in Poznan, Wielkopolskie, Poland. Specializing in AI-powered healthcare, StethoMe is paving the way for automatic and remote lung and heart screening.

As a pioneer in telemedicine, the company is leveraging artificial intelligence to detect abnormalities in the respiratory system. Its smart, wireless stethoscope, intuitive application and real-time AI analysis make auscultations easier than ever, allowing both individuals and healthcare providers to monitor respiratory and heart health from the comfort of their homes or healthcare centers.

Key Takeaways

  • StethoMe is revolutionizing remote heart and lung screening through AI-based healthcare technologies.
  • The company’s intelligent stethoscope and dedicated app allow for at-home auscultations and automatic real-time analyses.
  • StethoMe was recognized with several awards including a Winner at Baillie Gifford Discovery Competition and European Winner, BioTech Award at the Startup World Cup & Summit.
  • The product and AI algorithms are EU-certified as a Class 2a Medical Device.

What sets StethoMe apart is its commitment to accuracy and reliability. The company’s AI-powered system has been proven to confidently detect pathological sounds in the respiratory system of children, alongside providing automatic information about respiratory and heart rates. Moreover, it ensures the quality of the examinations it performs. By doing so, StethoMe is improving treatment efficiency and the accuracy of diagnoses.

However, what impresses even more is that the company is not operating in a vacuum. It has earned stellar recognition on the global stage, including laurels like the Baillie Gifford Discovery Competition and the EC2VC pitch Competition. Additionally, the device and AI algorithms have been certified in the EU as a class 2a medical device.

Keep exploring EU Startups  Is Recycling Automotive Catalysts the Future of Eco-Friendly Car Manufacturing?

Given its path-breaking contributions, the future seems immensely promising for StethoMe and the industry it operates in. As the European healthcare sector embraces technology more tightly, AI-assisted healthcare solutions like StethoMe’s will be indispensable. The success of telemedicine and at-home monitoring, which was further accelerated by the COVID-19 pandemic, only underscores the growing potential of the telehealth industry.

Going forward, it seems certain that StethoMe will continue to break barriers in AI healthcare. Wherever the company goes from here, it’ll be making leaps in terms of technology as well as healthcare. You can follow StethoMe here and here. Also, learn more about them on their website and LinkedIn.


Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!

Keep exploring EU Startups  Revolutionising Pharmaceutical Monitoring: Are Agile Methods the Future?
Previous Story

Is Personalized Learning the Future of European EdTech Industry?

Next Story

Is Advanced Energy Optimization Revolutionizing the Electric Vehicle Industry?